Persistent donor-specific alloreactivity may portend delayed liver rejection during drug minimization in children

Frontiers in Bioscience

Volumn 12, Issue 2, 2007, Pages 660-663

  Khera, Nandita ^a   Janosky, Janine ^a   Zeevi, Adriana ^a   Mazariegos, George ^a   Marcos, Amadeo ^a   Sindhi, Rakesh ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b FACS   (United States)

Author keywords

Delayed; Drug; Immunoreactivity; Minimization; Recurrent; Rejection; Review; Risk

Indexed keywords

EID: 34249814919     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2090     Document Type: Article

References (6)

1. Starzl TE. Back to the future. Transplantation. 79(9): 1009-14, (2005)
2. Fridell JA, Jain A, Reyes J, Biederman R, Green M, Sindhi R, Mazariegos GV. Causes of mortality beyond 1 year after primary pediatric liver transplant under Tacrolimus. Transplantation. 74(12): 1721-4, (2002)
3. Jain A, Reyes J, Kashyap R, Rohal S, Cacclarelli T, McMichael J. Rakela J. Starzl TE. Fung JJ. Liver transplantation under tacrolimus in infants, children, adults and seniors: 1000 consecutive cases: mean follow-up 7 years. Transplant Proceedings 30(4): 1403-4, (1998)
4. Toyoki Y. Renz JF. Mudge C. Ascher NL. Roberts JP. Rosenthal P. Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors. Pediatric Transplantation. 6(4):301-7, (2002)
5. Sindhi R, Magill A, Abdullah A, Seward J, Tresgaskes M, Bentlejewski C, Zeevi A. Enhanced Donor-specific Alloreactivity occurs independent of immunosuppression in children with early liver allograft rejection. Am J Transplant. 5. 96-102, (2005)
6. Hricik DE, Rodriguez V, Riley J, Bryan K, TaryLehmann M, Greenspan NS, Dejelo C, Schulak J, Heeger PS. Enzyme-linked Immunosorbent Spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant. 3. 878-884, (2003)